Forma Therapeutics Holdings Inc - ESG Rating & Company Profile powered by AI
If you work at Forma Therapeutics Holdings Inc and you wish to use your ESG rating, please contact us. Other corporations in the scoring peer group for Forma Therapeutics Holdings Inc are shown. The Sustainability rating for Forma Therapeutics Holdings Inc indicates the company's reporting of the UN Sustainable Development Goals.
Forma Therapeutics Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.4; made up of an environmental score of 6.4, social score of 3.2 and governance score of 6.7.
5.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 835 | Wuhan Keqian Biology Co Ltd | 5.5 | High |
| 835 | dorsaVi Ltd | 5.5 | High |
| 886 | Forma Therapeutics Holdings Inc | 5.4 | High |
| 886 | Avant Brands Inc | 5.4 | High |
| 886 | Antengene Corporation Ltd | 5.4 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Forma Therapeutics Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc report the average age of the workforce?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc offer flexible work?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc conduct supply chain audits?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose water use targets?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Forma Therapeutics Holdings Inc have a product recall in the last two years?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Forma Therapeutics Holdings Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose parental leave metrics?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Forma Therapeutics Holdings Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose its waste policy?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc report according to TCFD requirements?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose energy use targets?
Sign up for free to unlockDoes Forma Therapeutics Holdings Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Forma Therapeutics Holdings Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Forma Therapeutics Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma; and FT-8225, a liver-targeted fatty-acid synthase inhibitor designed to block de novo lipogenesis in the liver. Forma Therapeutics Holdings, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts.